IPO Report: Concert Pharmaceuticals (CNCE)

Francis Gaskins | |

Concert Pharmaceuticals (CNCE)  is a clinical stage biopharmaceutical company applying its extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs Seven

8 IPOs Planned for the Week of February 10

Francis Gaskins | |

The full IPO calendar is available at Ranked by size of IPO, largest first. (1)  Based in Troy, MI, Talmer Bancorp (TLMR) scheduled a $210 million IPO on the Nasdaq with a

Equities Sector Coverage: Wall Street Extend Gains As Stocks Push Higher

Sector Recap | |

Challenger, Grey and Christmas reported that planned layoffs rose to 115,730 in September to levels not seen since April 2009. ADP reported to the contrary that the private sector added 91,000

Sponsored Financial Content

Market Movers